EP2566550A1

EP2566550A1 - Inhaler which creates turbulance

Info

Publication number: EP2566550A1
Application number: EP11728969A
Authority: EP
Inventors: Mahmut Bilgic
Original assignee: Individual
Current assignee: SIMA PATENT VE LISANSLAMA HIZMETLERI LTDSTI
Priority date: 2010-04-13
Filing date: 2011-04-13
Publication date: 2013-03-13
Also published as: IN2012DN04989A; WO2011129790A1; EA201201389A1; JP2013523378A

Abstract

The present invention relates to an inhaler which is appropriate for delivering the medicament in dry powder form used in the treatment of respiratory diseases, particularly in asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis by the oral route and has a mechanism preventing the problems resulting from inadvertent actuation of the device.

Description

INHALER WHICH CREATES TURBULANCE Field of the Invention

The present invention relates to an inhaler appropriate for delivering the medicament in dry powder form used in the treatment of respiratory diseases, particularly in asthma and chronic obstructive pulmonary disease (COPD). In addition, the present invention relates to an inhaler which comprises blister package appropriate for carrying medicament in dry powder form and is used so as to achieve an effective inhalation.

Description of the Prior Art

It is rather common to use inhalers for delivering medicaments utilized in the treatment and prophylaxis of respiratory diseases by the oral route. Inhalation treatment is the most commonly preferred treatment method in these diseases as the inhalers provide ease of use; the medicaments have rapider onset of time resulting from local administration and they have fewer side effects. Various inhalers have been designed in order to provide effective and sufficient delivery of the medicaments used in the treatment of respiratory diseases, particularly in asthma and chronic obstructive pulmonary disease. These inhalers vary according to their operating mechanisms and the physical form of the medicament to be delivered.

In the inhalers used to deliver the medicaments in dry powder form, the medicament is carried in reservoirs, capsules or blisters packages. It is highly significant to provide the delivery of sufficient amounts of the medicament to the patient since the required amount of the dry powder medicament to be delivered to the patient for each inhalation is very low.

Generally, one blister pocket is opened in response to each actuation of the dry powder inhalers comprising blister packages and one dose of dry powder medicament contained in the pocket is inhaled upon the respiration of the patient. As the active agents used in inhalation treatment have quite strong effects, the amount of active agent comprised in a dry powder medicament is rather low. Therefore, it is essential that the required amount of active agent for an effective inhalation is absorbed in the lungs of the patient because absorption of less than the required amount of active agent is insufficient for an effective inhalation. In addition, the medicament in dry powder form has to have the appropriate particle size distribution for the required amount of the active agent comprised by the dry powder medicament in the opened blister to be able to reach the lungs. The particles having a particle size larger than 20 μιη accumulate in oral cavity and throat of the patient while the particles having a smaller particle size than 1 μιη adheres to esophagus or exits the body via the respiration of the patient. The particle size of the particles absorbed by the alveolus in the lungs is in the range of 1 μπι to 5 μπι. Thus, the particle size of the active agent has to be in the range of 1 μπι to 5 μπι in order to enable the absorption of the active agent comprised in the dry powder medicament by the alveolus in the lungs. The fact that the particle size increases as a result of the agglomeration of the active agent particles of very low amounts causes the required amount of the active agent to fail to reach the lungs and /or fail to be absorbed in the lungs. Failure to absorb the sufficient amount of the active agent in the lungs, on the other hand, results in failure to provide the desired effect or an effective inhalation.

In addition, it is another significant factor that the blister opened in response to each actuation of the inhaler has a high discharge capacity for the required amount of the active agent to be inhaled. Blister's having a high discharge capacity refers that almost the entire dry powder medicament contained in the blister pocket is discharged during the inhalation. To this end, the inhaler should hold the specifications that enable the inhalation of the dry powder medicament in each opened blister pocket with high discharge capacity.

The inhalation device marketed under the trade mark Diskus® by GlaxoSmithKlein is one of the most well-known dry powder inhalers on the market. This device comprises a blister strip package in which the dry powder medicament is carried and operates with a slide mechanism. However, Diskus® inhaler remains incapable to achieve an effective inhalation as it does not hold any specifications that can eliminate or prevent the problems mentioned above.

When the inhalers developed or present on the market are taken into consideration, there seems need for an inhaler which guarantees the dispersion of the agglomeration that the dry powder medicament particles contained in each blister pocket of the blister pack create, and therefore the delivery of the active agent particles comprised in the dry powder medicament at appropriate particle size and required amount to the patient's lungs.

The present invention relates to an inhaler which enables the inhalation of the active agent comprised in the dry powder medicament stored in each blister pocket of the blister pack at an appropriate particle size so as to achieve an effective inhalation, and the absorption of required amount of the active agent from the patient's lungs. Moreover, the present invention relates to an inhaler provides the blister pockets each of which contains medicament in dry powder form to have high discharge capacity so as to enable the delivery of required amount of the active agent to the patient.

Summary of the Invention

An inhaler suitable for delivery of the medicament in dry powder form according to the present invention comprising;

- a blister package composed of a plurality of blister pockets each of which comprises medicament in dry powder form and which are spaced at equal intervals;

- a mouthpiece enabling the patient to inhale the medicament in dry powder form from the opened blister ;

- a rotatable mouthpiece cover covering the mouthpiece;

- a gear mechanism enabling the blister package to be indexed and the medicament in dry powder form to become ready for inhalation;

- a housing situated between the upper housing member and the lower housing member in which the blister package and the gear mechanism are enclosed;

- at least one air inlet allowing the external air in the device, and

- a manifold through which the air entering from the air inlet passes is characterized in the apertures on the opposite walls in the second part of the manifold that is partitioned off from the first part of the two-part manifold where the air entering the device through at least one air inlet upon the inhalation of the patient entrains the dry powder medicament in the blister in order to create turbulence.

The inhaler pertaining to the present invention is preferably actuated by the rotation of the mouthpiece cover in terms of providing ease of use to the patients. For the dry powder medicament prepared for inhalation upon the rotation of the mouthpiece cover to be inhaled, the patient should seal his oral cavity on the mouthpiece and breathe in. While the patient breathes in, the external air enters the manifold passing through the air inlet. There are two air apertures with four sub-apertures on the edge of the manifold that is close to the blister and these apertures are partitioned off from each other. Since the apertures with four sub- apertures on the edge of the manifold are partitioned off, the manifold is divided into two as the first and the second part as well. According to this, there is one air aperture with four sub- apertures on the edge of the first part of the manifold which is close to the blister while there is another air aperture with four sub-apertures on the second part of the manifold which is close to the blister. In this way, some part of the air passing through the air aperture upon the inhalation of the patient enters in the blister from the air aperture on the first part of the manifold which is close to the blister. It entrains one dose of the dry powder medicament in the blister to the second part of the manifold through the air aperture with four sub-apertures on the edge of the manifold which is close to the blister. The air entering the inhaler upon the inhalation of the patient which passes through two air apertures on the opposite walls of the second part of the manifold at the same or different speed creates turbulence there. Thus, it is provided that the agglomeration in the dry powder medicament entrained to the second part of the manifold is dispersed and the dry powder medicament is inhaled at the appropriate particle size distribution. The medicament in dry powder form entrained to the second part of the manifold is delivered to the patient via the mouthpiece.

According to the present invention, the inhaler is an easy-grip, manual device which is appropriate for delivering medicament in dry powder form.

The housing of the device pertaining to the present invention has been designed such that each component of the blister package and the gear mechanism which have a significant role in enabling the device to work properly is situated accurately and works harmoniously. To this end, the housing is divided into several compartments. The used portion and the unused portion of the blister package are accommodated in separated compartments in order to prevent the medicament in dry powder form remained in the opened blister pocket to spill on the other components of the housing. Furthermore, the housing also comprise the beak which enables the blister package to be peeled and the manifold through which the dry powder medicament in the open blister passes before reaching the mouthpiece during the inhalation. In addition, the housing can be in any appropriate shape while it is preferably elliptic or circular.

The upper and the lower housing members interlock with each other and enclose the housing in order to keep the housing and the gear mechanism fixed together. The mouthpiece cover hiding the mouthpiece is rotated by being slid on the upper and lower housing members. The grids on the surface of the lower and the upper housing members provide an effective actuation by preventing the slipping of the finger while rotating the mouthpiece cover. The upper and the lower housing members can be in any appropriate shape or size which provides ease of use.

The mouthpiece cover hiding the mouthpiece of the device pertaining to the present invention has been designed such that it also provides to actuate the device. Before each inhalation, both the mouthpiece is uncovered and one dose of the medicament in dry powder becomes ready for inhalation as one of the blister pockets is opened as a result of the mouthpiece cover's preferably being manually rotated along the path restricted by the engagement of the protrusions on the upper and the lower housing members. The rotational path on which the cover moves is restricted on both ends by the protrusions of the upper and the lower housing members. The constant-distance path that the protrusions of the upper and the lower housing members define results in the mouthpiece cover's being rotated by the same angle in response to the each actuation of the device.

The mouthpiece cover that actuates the device can solely be in two positions. Holding the carved part on one end, the mouthpiece cover can be easily shifted from the first position to the second position. The mouthpiece is completely hidden when the mouthpiece cover is in the first position and the device is on standby mode. When the mouthpiece cover is in the second position, the mouthpiece is completely exposed and one dose of the medicament in dry powder form is prepared for inhalation upon the actuation of the device.

The mouthpiece cover of the device is joined with the gear mechanism by the connection points. One end of the drive gear passes through the center of the lower housing member and tightly joins with the mouthpiece cover in one connection point while the other end passes through the center of the upper housing member and tightly joins with the mouthpiece cover in the other connection point. For each end of the drive gear to make a fixed connection between the connection points of the mouthpiece cover, one side cover is used for each end of the drive gear. The ends of the drive gear are carved for the ends of the side covers to be joined with each end of the drive gear from inside such that the ends of the side covers can tightly interlock with it. Inner faces of these carved parts in each end of the drive gear have a matching shape with the shapes of the ends of the side covers. These side covers that attach with the each end of the drive gear passes through the connection point and provide the mouthpiece cover to synchronize with the drive gear. On each connection point of the mouthpiece cover, there is a stabilizing resilient cover. The extensions under the stabilizing resilient covers pass through the holes on the upper or the lower housing member according to the position of the connection point and provide the stabilizing resilient covers that they connect with to remain stable. The rotation of the mouthpiece cover is prevented from both sides as the pawl under each of the stabilizing resilient covers in both sides of the device interlocks with the mouthpiece cover. Before the inhalation, the resilient parts of each stabilizing resilient cover which are compatible with the shape of the fingers are pressed on for raising the pawls and releasing the mouthpiece cover in order to move the mouthpiece cover which actuates the device. Thus, the mouthpiece cover can easily be rotated when the resilient parts of each stabilizing resilient cover on both sides of the device which match with the shape of the fingers are pressed on. When the resilient parts of the stabilizing resilient covers are not pressed on, the pawls under the stabilizing resilient covers do not allow the mouthpiece cover to move in any circumstances.

The mouthpiece cover that actuates the device can solely be in two positions. When the mouthpiece cover is in the first position, it leans on the protruding part in one end of the rotational path. The mouthpiece is completely hidden when the mouthpiece cover is in the first position and the device is on standby mode. When the mouthpiece cover is in the second position, it leans on the protruding part on the other end of the rotational path and one dose of the medicament in dry powder form is prepared for inhalation upon the actuation of the device.

Each gear of the gear mechanism in the device according to the present invention is directly or indirectly engages with each other. The drive gear, which is one of the components of the gear mechanism, provides the mouthpiece cover to trigger the gear mechanism. In each actuation of the device, the constant-angle rotational movement of the cover is transmitted by the indexing ratchet wheel which interlocks with the indexing wheel via the drive gear. The indexing wheel that synchronizes with the indexing ratchet wheel is engaged with the winding wheel gear and the pinion gear and causes them to move as well. Therefore, with the rotation of the indexing wheel, both the lid sheet of the blister package is provided to be coiled on the wings of the winding wheel as the winding wheel is rotated by the mechanism gear that engages with the winding wheel gear, and the counter gear that engages with the small gear under the base gear is provided to be rotated by means of the base gear that engages with the pinion gear. According to the present invention, the indexing wheel is another component of the gear mechanism and it provides the blister package to be indexed properly and the opened blisters to be positioned accurately. The recesses of the indexing wheel match with the shape of the blister package and the blister pockets of the blister package are received in these recesses in sequence while the indexing wheel rotates. There are preferably 8 recesses on the indexing wheel. Therefore, the indexing wheel is supposed to rotate by the same angle in response to each actuation of the device for the opened blister pocket to be positioned accurately. The angle between each recess is equal and 45°. For the blister pocket opened in response to each actuation of the inhaler to be accurately positioned, the indexing wheel has to rotate by the same angle each time. As the indexing wheel rotates by the same angle, the blister package is indexed to the same extent and the opened blister pocket is provided to be accurately positioned.

At least one stopper component is arranged in any suitable part of the device in order to provide the blister package to be precisely positioned. The stopper can be in any suitable shape to execute said task.

The counter gear in the device pertaining to the present invention displays the number of the unused blister pockets remained in the device. In response to the actuation of the device by the mouthpiece cover, the mouthpiece is uncovered, the blister package is indexed and one dose of the dry powder medicament is prepared for inhalation while the counter gear rotates as well. Thus, the movement of the mouthpiece cover causes the mouthpiece cover to be uncovered; one dose of the dry powder medicament to be ready for inhalation after the blister pocket is opened as well as providing the counter gear to rotate and display the new value of the unused blister pockets remained.

On the counter gear, there exist numerals equal to the number of the blister pockets present in the device and they are spaced by equal angles. In a device comprising 60 doses, the angle between the numerals is approximately 5°. The counter gear rotates as a result of the reflection of the rotation of the indexing wheel via the pinion gear and the base gear. In response to the each actuation of the device, rotation of the indexing wheel by the same angle each time due to the accurate transmission of the movement of the mouthpiece to the gear mechanism via the drive gear results in the rotation of the counter wheel approximately by the same angle as well and each numeral on the counter wheel is clearly seen through the display aperture on the upper housing member. Therefore, the patient makes sure about the number of the unused blister pockets remained in the device.

Before the inhalation, the device is actuated by pressing on the stabilizing resilient covers on both faces of the device and rotating the mouthpiece cover along the rotational path, and the drive gear which is joined with the both connection points of the mouthpiece cover via the side covers precisely transmits the movement of the mouthpiece cover to the indexing ratchet wheel owing to the side covers upon the actuation of the device. The indexing ratchet wheel interlocks with the indexing wheel from inside thanks to its arms and enables the indexing wheel to rotate 45°. Upon the indexing wheel's movement, the blister package is indexed and it is peeled by means of the beak present in the housing. As the indexing wheel engages with the winding wheel gear and the pinion gear, these gears synchronize with the indexing wheel. Since the mechanism gear engages both with the winding wheel gear and the winding wheel, the rotation of the winding wheel gear causes the winding wheel to move and lid sheet of the blister package coils on the winding wheel tightly. The pinion gear engages with the base gear while the small gear under the base gear engages with the counter gear. In brief, the movement of the mouthpiece cover along the rotational path causes the blister package to be accurately positioned as a result of the rotation of the indexing wheel by 45 degrees and the number of the unused blisters remained in the device is clearly seen through the display aperture as the counter gear rotates approximately by 5 degrees.

The inhaler according to any of the proceeding claims, further comprising a blister package composed of a plurality of blister pockets each of which comprises medicament in dry powder form and which are spaced at equal intervals. The blister package carries the medicament in dry powder form in one-dose portions and it is preferably a blister strip and it is preferably peelable. The blister pockets comprised in the blister package are spaced in equal intervals and each of them carries one dose of the medicament in dry powder form.

While the blister package is indexed on the indexing wheel, the beak on the housing peels the blister. Therefore, one dose dry powder medicament becomes ready for inhalation after the blister package is peeled to be opened in each actuation of the device.

The base sheet of the blister package on which the blister cavities are spaced is accumulated in the separated compartment of the housing. The lid sheet that provides impermeability of the blister package, on the other hand, is coiled on the winding wheel which is one of the components of the gear mechanism positioned in the other side of the housing.

The blister opened by the beak is situated immediately under the manifold. Upon the inhalation of the patient, the airflow that preferably enters the device through at least one air inlet on the upper housing member entrains the dry powder medicament in the opened blister pocket via the manifold to the mouthpiece and enables the delivery of said medicament to the patient. The air inlet on the upper housing member that allows the entry of air can be in any suitable shape and size that also enable external air to enter the device easily and at a convenient speed.

The mouthpiece is designed to fit the mouth for the patient to comfortably inhale the medicament in dry powder form. According to the shape of the device, the mouthpiece can be in any suitable shape or size as well as being fixed or movable. Furthermore, it can be attached or unattached to the upper and/or the lower cover.

The air inlet that the external airflow passes through is preferably designed not to be close where the patient holds the device in order not to prevent the air flow. Furthermore, in order to deliver the required amount of the dry powder medicament in the opened blister to the patient, the air inlet has been designed such that it allows the entry of the airflow through the air inlet by a convenient angle.

When the manifold between the opened blister and the mouthpiece is considered as a whole, one end of its communicates with the opened blister while the other end communicates with the mouthpiece. The manifold is connected to the mouthpiece by the tapered channel. When the patient breathes in, the external air passes through the air aperture and reaches the manifold. There are two air apertures with four sub-apertures on the edge of the manifold that is close to the blister and these air apertures are partitioned off from each other. As these air apertures on the edge of the manifold are partitioned off, also the manifold is divided into two parts as the first part and the second part. According to this, there is one air aperture with four sub-apertures on the edge of the first part of the manifold which is close to the blister while there is another air aperture with four sub-apertures on the second part of the manifold which is close to the blister. In this way, some part of the air passing through the air aperture upon the inhalation of the patient enters in the opened blister from the air aperture on the first part of the manifold which is close to the blister. It entrains the one dose of the dry powder medicament in the blister to the second part of the manifold through the air aperture with four sub-apertures on the edge of the manifold which is close to the blister. The air entering the inhaler upon the inhalation of the patient which passes through two air apertures on the opposite walls of the second part of the manifold at the same or different speed creates turbulence there. Thus, it is provided that the dry powder medicament is inhaled at the appropriate particle size distribution as a result of the dispersion of the agglomeration in the dry powder medicament entrained to the second part of the manifold. The medicament in dry powder form entrained to the second part of the manifold is delivered to the patient via the mouthpiece. The manifold can be in appropriate shape while the distance between the end of the manifold communicating with the mouthpiece and the end of its communicating with the blister is at least 1 mm.

There can be at least one aperture on each of the opposite walls in the second part of the manifold. One of the said walls in the second part of the manifold is the one partitioning the manifold into two parts and lying between the apertures with four sub-apertures. These apertures can be in any appropriate shape and their cross-sections can be equal or different. However, the cross-sections of these apertures are preferably different to provide the airflows passing through these apertures to be at different speed. The cross-section of each aperture is in the range of 0,01 mm² to 27 mm², preferably in the range of 0,01 mm² to 17 mm², more preferably in the range of 0,01 mm to 7 mm . The said apertures can be positioned exactly opposite or asymmetrically on the appropriate spots of the walls. These apertures on the walls of the second part of the manifold through which the medicament in dry powder form passes provide to disperse the agglomeration of the dry powder medicament by creating an effective turbulence and prevent dry powder medicament particles to accumulate on the walls of the second part of the manifold.

The air apertures with four sub-apertures on the edge of the manifold that is close to the blister are preferably shaped circular. The distance between the centers of these apertures is one of the factors affecting the discharge capacity of the opened blister because accurate positioning of these air apertures causes the sufficient amount of the external air to enter into the opened blister and entrain the entire dry powder medicament in the blister from the blister to the manifold. According to this, the distance between the centers of the two apertures with four sub-apertures in the inhaler is in the range of 3,0 mm to 3,8 mm, more preferably in the range of 3,2 mm to 3,6 mm. The term "an effective inhalation" used throughout the text refers to the desired result which is induced as a result of the delivery of the active agent in quantities required for inhalation treatment to the patient's lungs.

Each component of the device pertaining to the present invention can be made of any appropriate substance while it is preferably made of plastics. These plastic substances are selected from a group comprising styrene-acrylonitrile, polyoxymethylene, acrylic- polymethylmetacrylate, cellulose acetate, polyetheretherketone, polyvinyl choloride, polyethylene, polypropylene, acrylonitrile butadiene styrene, polycarbonate, polyamide, polystyrene, polyurathane or fluoropolymer types while it is more preferably polyoxymethylene. The components made of plastics can be produced by methods such as injection molding. Furthermore, each component of the device can be in any appropriate color.

The lid and the base sheets constituting the blister package preferably consist of a plurality of layers. Each of these layers are preferably chosen from a group comprising polymeric layers that are made of various polymeric substances; aluminum foil and fluoropolymer film.

According to the present invention, the lid and base sheets composing the blister package are sealed very tightly by at least one of the methods comprising cold formed bonding, hot metal bonding, hot metal welding, radio frequency welding, laser welding or ultrasonic welding in order to provide impermeability, more preferably by cold formed bonding method. Since these cold formed bonding methods can be carried out at lower temperatures than hot sealing methods, they are the most appropriate methods to use in the case that the medicament carried in the blister is heat sensitive.

Fluoropolymer film is a polymeric film which is used in blister packs and provides excellent moisture barrier. This chemically inert polymeric film does not cause any change in the taste of the formulation when it is in contact with the dry powder formulation. In addition, it easily constitutes a layered structure with the other polymeric layers which are composed of various polymers. It is appropriate to be transacted with heat.

For preserving the stability of the dry powder formulation stored in the blister package, preferably at least one of the polymeric layers comprises at least one desiccant agent including silica gel, zeolite, alumina, bauxite, anhydrous calcium sulfate, activated carbon and clay which has the property of water absorption in order to decrease gas and moisture permeability of the layer.

According to the invention, the thickness of the aluminum foil in the lid and the base sheets of the blister package are preferably chosen to be in the range of 5 to 80 μιη, more preferably in the range of 15 to 65 μπι.

According to the invention, the polymeric layers in the lid and the base sheets of the blister pack are made of the same or different polymers. The thickness of these polymeric layers varies according to the type of the polymeric substance used and its properties while they are preferably in the range of 5 to 100 μπι, more preferably in the range of 15 to 60 μιη.

The polymers composing the polymeric layer are preferably selected from thermoplastics such as polyethylene, polypropylene, polystyrene, polyolefin, polyamide, polyvinyl chloride, polyurethane or synthetic polymers.

The blister pockets in the blister package can be in any appropriate shape. The plurality of blister pockets spaced at equal intervals on the base sheet of the blister package can be in the same or different shape, structure or volume.

The reference numbers of the drawings added to exemplify the present invention and the detailed description of the invention according to these drawings are given below but the scope of the invention should not be limited to these drawings.

Brief Description of the Drawings

Figure 1 is a perspective view of an inhaler according to the inhaler described in the present invention;

Figure 2 is an exploded view of the inhaler pertaining to the invention;

Figure 3 is a perspective view of the blister pack for use with the inhaler pertaining to the invention;

Figures 4a and 4b are perspective views of the housing of the inhaler according to the invention; Figures 4c is a perspective view of the housing of the inhaler according to the invention;

Figures 4d and 4e are cross-sectional views of the manifold part of the inhaler pertaining to the invention which is shown as X in figure 4c;

Figures 5 a and 5b are perspective views of upper and lower housing members of the inhaler according to the invention;

Figure 6a is a perspective view of the mouthpiece cover of the inhaler pertaining to the invention;

Figure 6b is an exploded view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention;

Figure 6c is a cross-sectional view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention;

Figure 6d is a cross-sectional view of the communication between the mouthpiece cover, the drive gear and the stabilizing resilient covers in the inhaler pertaining to the invention;

Figure 6e is an exploded view of the communication between the drive gear and the side covers in the inhaler pertaining to the invention;

Figure 6f is a cross-sectional view of the connection of the stabilizing resilient cover with the lower housing member in the inhaler pertaining to the invention;

Figures 7a- 7c are cross-sectional views of the engagement of the gears composing the gear mechanism with each other in the inhaler pertaining to the present invention;

Figure 8 is a cross-sectional view of the blister package delaminating in course of operation of the inhaler pertaining to the present invention;

Figure 9 is a perspective view of the counter gear used in the inhaler pertaining to the present invention.

Detailed Description of the Drawings

The inhaler (1) pertaining to the present invention comprises a gear mechanism situated in the housing (10) between the upper housing member (4a) and the lower housing member (4b) in order to enable the inhalation of the dry powder medicament carried in a blister package (15) as displayed in figures 1 and 2. Each component of the inhaler (1) is positioned at appropriate spots of the device to guarantee their working properly and accurately.

The inhaler (1) pertaining to the present invention shown in figure 1 is ready for inhalation. In this case, the mouthpiece cover (2) is in the second position and the mouthpiece (14) is entirely exposed. Rotating by holding on the carved part (2a) on one end, the mouthpiece cover (2) is switched to the second position from the first position wherein the mouthpiece is completely covered. In this way, the mouthpiece (14) is completely exposed when the mouthpiece cover (2) is switched to the second position from the first position and the gear mechanism is triggered by the drive gear (12). The drive gear (12) precisely transmits the movement of the mouthpiece cover (2) to the indexing ratchet wheel (3).

The indexing wheel (8) which engages with the indexing ratchet wheel (3) enables the blister package (15) shown in figure 3 to be indexed. The blister pockets (15a) composing the blister package are received in the recesses (8a) on the indexing wheel and the blister package (15) is indexed when the indexing wheel (8) rotates. In the inhaler pertaining to the present invention, shapes of the recesses (8a) on the indexing wheel (8) have been designed to match the shapes of the blister pockets (15) composing the blister package (15) for the blister package to be indexed properly.

The blister package (15) shown in figure 3 is composed of the lid sheet (15b) which provides impermeability and the base sheet (15c) on which the blister pockets (15a) are spaced at equal intervals. Each blister pocket contains medicament in dry powder form comprising one or more active agents.

The rotational movement that the mouthpiece cover (2) of the device executes while switching from the first position to the second is transmitted to the indexing ratchet wheel (3) via the drive gear (12) that the mouthpiece cover (2) engages with. As displayed in figure 2, arms (3a) of the indexing ratchet wheel interlocks with protrusions inside the indexing wheel (8) and rotates the indexing wheel (8) unidirectionally. Therefore, the blister package (15) is indexed forward while the indexing wheel (8a) rotates as the blister pockets (15a) composing the blister package (15) are received in the recesses (8a) of the indexing wheel. The beak (16) in the housing (10) provides the blister package (15) to be peeled while the blister package (15) is indexed and provides one blister pocket (15a) to be opened in response to each actuation of the device (1).

The winding wheel gear (6), which is another component of the gear mechanism, engages with the indexing wheel (8) as displayed in figure 2. The mechanism gear (5) that interlocks with the winding wheel (13) from inside has arms (5a) to interlock with the interior teeth of the winding wheel gear (6). When the indexing wheel (12) rotates the winding wheel gear (6), the winding wheel rotates unidirectionally owing to the arms of the mechanism gear (5a) which interlock with the interior teeth of the winding wheel gear (6) and the lid sheet (15b) which is peeled away while the blister package is indexed is tightly coiled on the wings (13a) of the winding wheel. The base sheet (15c) of the blister package (15) where the blister pockets are spaced is accumulated in a separate part (18a) of the device.

Different perspective views of the housing (10) wherein the gear mechanism and the other components of the inhaler (1) pertaining to the present invention are arranged are displayed in figures 4a and 4b. Furthermore, as can be seen in figures 4a and 4b, the housing (10) also comprises the other components having significant roles in the actuation of the device such as the beak (16), the manifold (20), the apertures with four sub-apertures (20a, 20b). Each component comprised in the housing is situated in appropriate parts of the housing (10) in order to enable the inhaler (1) to work properly. The drive gear (12) passes through the center (21) of the housing and joins the mouthpiece cover (2) at two points. The blister package (15) is in the lower part (17) of the housing as coiled up. In response to each actuation of the device (1), the blister package (15) is peeled by the beak (16) in the housing while being indexed by the indexing wheel (8) situated in the upper part (19) of the housing. The lid sheet (15b) of the blister package (15) which provides impermeability is indexed over the beak (16) and coiled on the winding wheel (13) which is situated in the side part (18) of the housing. The base sheet (15c) of the blister package (15) on which the blister pockets (15a) are spaced, on the other hand, is accumulated in the separated compartment (18a) of the housing (10). Upon the inhalation of the patient, the air passes through the air inlet with four sub-apertures (20a) under the manifold (20) into the opened blister pocket; entrains the dry powder medicament contained in the opened blister pocket (15a) in response to each actuation of the device; provides it to pass through the other aperture with four-sub-apertures (20b) and reach the mouthpiece via the manifold (20). A view of the cross-section of the housing component (10) which illustrated as X in figure 4c and includes the manifold part (20) is given in figures 4d and 4e. According to figure 4d, the blister pocket (15a) opened upon the actuation of the inhaler (1) is positioned immediately under the apertures with four sub-apertures (20a, 20b). There are two apertures with four sub- apertures (20a, 20b) on the edge of the manifold (20) which is close to the blister (15a) and they are partitioned off from each other by a wall. This wall is named as wall A in figure 4c and it partitions the manifold (20) into two parts. Wall A lies between the first part (20c) and the second part (20d) of the manifold and it belongs to both the first part (20c) and the second part (20d) of the manifold. Upon the respiration of the patient so as to inhale the medicament in dry powder form in the opened blister pocket (15a), the external air that enters the inhaler passing through the air inlet (22) on the upper housing member reaches the first part (20c) of the manifold. Some part of this airflow reaches the opened blister (15a) by passing through the aperture with four sub-apertures (20a) on the edge of the first part of the manifold. The airflow reaching the opened blister pocket (15a) entrains the dry powder medicament in the blister to the second part (20d) of the manifold through the other aperture with four sub- apertures (20b) on the edge of the manifold which is close to the blister. Wall A and wall B shown in figure 4c are two opposite walls in the second part (20d) of the manifold. Some part of the external air which runs through the air inlet (22) and enters the inhaler (1) upon the patient's breathing in passes through the first part (20c) of the manifold and reaches the opened blister pocket (15a) while the rest passes through the aperture (20e) on wall A and the aperture (20f) on wall B and enters the second part (20d) of the manifold. The apertures (20e; 20f) on wall A and wall B are asymmetrically positioned. Shapes and the cross-sections of the apertures (20e; 20f) on wall A and wall B can be identical or different. Thus, an effective turbulence is created in the second part (20d) of the manifold as the speed of the airflow entering through the aperture (20e) on wall A and the speed of the airflow entering through the aperture (20f) on wall B are different. The created turbulence disperse the agglomeration of the dry powder medicament entrained to the second part (20d) of the manifold and provides the dry powder medicament to be delivered to the patient at appropriate particle size distribution.

Another cross-sectional view of the part of the housing which is shown as X in figure 4c is given in figure 4e. In the cross-sectional view of the manifold illustrated in figure 4e, there are two apertures (20f; 20g) on wall B of the manifold differently from figure 4d. The apertures (20e; 20f) on wall A and wall B are asymmetrically positioned with respect to each other. The shapes and the cross-sections of the apertures (20e; 20f; 20f) on wall A and wall B which allow the air in the second part (20d) of the manifold can be identical or different. Thus, the airflow entering in through the aperture (20e) on wall A and the airflows entering in through the apertures (20f; 20g) on wall B create an effective turbulence in the second part (20d) of the manifold. This turbulence disperses the agglomeration in the dry powder medicament entrained to the second part (20d) of the manifold and enables the medicament in dry powder form to be delivered to the patient at an appropriate particle size distribution.

The housing (10) and the other components of the inhaler (1) pertaining to the present invention are stably kept together as the upper housing member (4a) and the lower housing member (4b) displayed in figures 5a and 5b are joined together. The engagement tabs (28) on the inside surface of the lower housing member (4b) engage with the engagement recesses (27) on the inside surface of the upper housing member (4a) and the upper and lower housing members are fixed tightly. Therefore, the protrusions (23a, 23b) on the upper housing member (4a) and the protrusions (24a, 24b) on the lower housing member (4b) are joined end to end and they define the restricted path for the rotational movement of the mouthpiece cover (2). The mouthpiece cover (2) can be moved along this path. When the mouthpiece cover (2) is in the first position, the mouthpiece is completely covered, the device is in standby mode and the mouthpiece cover (2) leans on the first protrusion (23 a) on the upper housing member and the first protrusion (24a) on the lower housing member. The mouthpiece (2) is manually slid along the rotational path with the help of the carved part to switch to the second position. The mouthpiece is completely exposed when the cover is in this position, one dose of the dry powder medicament is ready for inhalation and the mouthpiece cover (2) leans on the second protrusion (23b) on the upper housing member and the second protrusion (24b) on the lower housing member.

As displayed in figures 5a and 5b, one half (25a) of the tapered channel that interconnects the manifold (20) that exist in the housing (10) with the mouthpiece (14) is comprised in the upper housing member (4a) while the other half of it (25b) is comprised in the lower housing member (4b). The channel is constituted as a whole when the upper (4a) and the lower (4b) housing members are joined together. Upon the inhalation of the patient, the air that enters the device through the air inlet (22) arranged in the upper housing member (4a) passes through the aperture with four sub-apertures (20a), reaches the opened blister (15a) and entrains the dry powder medicament there to the manifold (20) by passing it through the other aperture with four sub-apertures (20b). The grids on the upper housing member (23e, 23f) and the grids on the lower housing member (24e, 24f) prevent the slips of fingers when rotating the mouthpiece cover.

The mouthpiece cover (2) of the inhaler pertaining to the present invention is displayed in figure 6a. The carved part (2a) in one end of the device enables to easily move the mouthpiece cover manually. The mouthpiece cover (2) is joined with the gear mechanism via the connection points. The drive gear (12) is joined with the connection points (29, 30) of the mouthpiece cover via the side covers (31a, 31c) as it can clearly be seen in figures 6b, 6c and 6d illustrating the communication between the mouthpiece cover (2), the drive gear (12), side covers (31a, 31c) and the stabilizing resilient covers (32,33). Each of these side covers (31a; 31c) passes through the center (4d) of the upper housing member or the center (4e) of the lower housing member and joins with the end (12a; 12b) of the drive gear. It can clearly be seen in figure 6d that the both ends (12a; 12b) of the drive gear is carved such that the end of the side cover (31b; 3 Id) can pass through. Each end of the side covers (3 Id; 31b) passes through one of the connection points (29; 30) of the mouthpiece cover and it is received in the recess in one end (12b; 12a) of the drive gear, thus it provides to tightly and stably interconnect the mouthpiece cover (2) with the drive gear (12). It is provided that the mouthpiece cover (2) synchronizes with the drive gear (12) as the connection point (29; 30) of the mouthpiece cover which has a matching shape with the ends (3 Id; 31b) of the side covers that passes through it on both sides of the device and the end (12b; 12d) of the drive gear that it communicates with are on the same component.

As is seen from figures 6a-6e, the shapes of the ends (31b; 3 Id) of the side covers that are received in the carved parts on the ends of the drive gear and the shapes of the connection points (29, 30) of the mouthpiece cover are not identical since the two ends (12a, 12b) of the drive gear are not identical.

There is one stabilizing resilient cover (33; 32) on each connection point (29; 30) of the mouthpiece and on each side cover (31c; 31a), as displayed in figures 2, 6a-6d and 6f. When the mouthpiece cover (2) is in the first position, the pawls (32a, 33a) under the stabilizing resilient covers, which are on the connection points (29, 30) of the mouthpiece, interlock with the mouthpiece cover (2) on both sides as clearly seen in figures 6c and 6d. The pawl (33 a) under the stabilizing resilient cover that is on the first connection point (29) interlocks with the mouthpiece cover on one side (figure 6c). Identically, the pawl (32a) under the stabilizing resilient cover that is on the second connection point (30) of the mouthpiece cover interlocks with the mouthpiece cover (2) on the other side (figure 6d). Thus, the pawls (32a, 33a) under the stabilizing resilient covers interlock with the mouthpiece cover (2) on both sides and prevent its rotation, and therefore the inadvertent actuation of the gear mechanism.

The extensions (32b, 32c; 33b, 33c) under the stabilizing resilient covers pass through the apertures (23 c, 23 d; 24c, 24d) on the upper and the lower housing members illustrated in figures 5a and 5b and provide the stabilizing resilient covers to remain stable. Namely, the extensions (33b; 33c) under the stabilizing resilient cover that is on the first connection point (29) of the mouthpiece cover pass through the apertures (23c; 23d) on the upper housing member and provide the stabilizing resilient cover (33) to be stably joined with the device. Identically, the extensions (32b, 32c) under the stabilizing resilient cover on the second connection point (30) of the mouthpiece cover pass through the apertures (24c, 24d) on the lower housing member and provide the stabilizing resilient cover (32) to be stably joined with the device as clearly illustrated in figure 6f.

Before the inhalation, the resilient parts (32d, 33 d) of each stabilizing resilient cover illustrated in figures 6c and 6d are pressed on for raising the pawls (32a, 33a) and releasing the mouthpiece cover (2) in order to actuate the gear mechanism of the device to prepare one dose of dry powder medicament before inhalation. Therefore, the gear mechanism of the device is actuated and one blister pocket (15a) is opened for one dose of the dry powder medicament to be ready for inhalation when the resilient parts (32d, 33d) of the stabilizing resilient covers are pressed on and the mouthpiece cover (2) is switched from the first position to the second position simultaneously. The necessity to press on the resilient parts (32d, 33 d) of the stabilizing resilient covers so as to actuate the gear mechanism preclude the consequences which may result from accidental and inadvertent actuations of the gear mechanism.

In figure 7a, it is displayed that the stopper (26) interlocks with the tooth of the indexing ratchet wheel (3) and hinders its rotation. The rotational movement of the mouthpiece cover (2) by the same angle in response to each actuation of the device (1) is accurately transmitted to the indexing ratchet wheel (3) by the drive gear (12) which engages with the mouthpiece cover (2) on its both ends and the drive gear (12) is enabled to rotate by the same angle in each actuation of the device (1). The stopper component (26) in the lower housing member (4b) prevents the backwards movement of the blister package (15) indexed by the indexing wheel (8) which synchronizes with the indexing ratchet wheel by keeping the position of the indexing ratchet wheel (3) fixed and provides the blister package (15) to be precisely positioned.

As can be seen in figure 7b, the indexing wheel (8) which synchronizes with the indexing ratchet wheel (3) is engaged with the winding wheel gear (6) and the pinion gear (11) and the rotation of the indexing wheel (8) causes the pinion gear (11) and the winding wheel gear (6) to rotate. Thus, both the peeled lid sheet (15b) of the blister package (15) which is indexed by the rotation of the indexing wheel (8) is tightly coiled on the winding wheel (13) engaging with the winding wheel gear (6) and also the counter wheel (9) is provided to be moved by the pinion gear (11) and the base gear (7) as a result of the rotation of the indexing wheel (8).

As is seen in figure 8, the lid sheet (15b) of the blister package (15) which is peeled away by the beak (16) and the base sheet (15c) are enclosed in separate compartments. The lid sheet (15b) that provides impermeability is indexed over the beak (16) and tightly coiled on the wings (13a) of the winding wheel. The base sheet (15c) of the blister package (15) where the blister pockets (15a) each of which carries one dose of the dry powder medicament are spaced is accumulated in the separated compartment (18a) of the housing (10). In response to each actuation of the device (1), one dose of the dry powder medicament which is prepared for inhalation after one blister pocket (15a) is opened and the air entering the device through the air inlet (22) upon the inhalation of the patient provides to deliver one dose of the dry powder medicament to the patient by entraining it from the blister pocket (15a) to the mouthpiece (14).

The rotation of the indexing wheel (8) is transmitted to the base gear (7) engaging with the pinion gear (11) by the pinion gear (11). The small gear which is under the base gear (7) as attached to it engages with the counter gear (9) (figure 7c). Thus, the movement of the indexing wheel (8) is transmitted to the counter wheel (9) shown in figure 9 by the pinion gear (11) and the base gear. There are numerals incrementing from 1 to 60 in the counter gear (9) displayed in figure 9. The angles between these numerals are all equal and approximately 5°. In response to each actuation of the device, the counter gear rotates approximately 5° and the number of the unused blister pockets remained in the device are clearly seen through the display aperture (4c) on the lower housing member (4b). In use of the device described in figures 1-9, the mouthpiece (14) is exposed when the mouthpiece cover (2) is slid from the first position to the second on the upper housing member (4a) and the lower housing member (4b); the gear mechanism is triggered by the drive gear (12) and one dose of dry powder medicament is prepared for inhalation; the counter gear (9) is indexed and the numeral seen through the display aperture (4c) on the lower housing member (4b) is incremented. After the inhalation is realized, the mouthpiece cover (2) is solely moved from the second position to the first position wherein the mouthpiece (14) is completely covered.

The medicament in dry powder form which is stored in blister cavities is manufactured according to the prior art. According to the present invention, the particle sizes of the active agents comprised in the dry powder medicament are smaller than 20 μπι, preferably smaller than 10 μηι.

The inhaler pertaining to the present invention has been designed so as to deliver the dry powder medicament used in monotherapy or combined therapy. The term "monotherapy" refers to inhalation treatments in which dry powder medicaments comprising a single active agent are used whereas the term "combined therapy" refers to inhalation treatments in which dry powder medicaments comprising more than one active agents are use used.

The dry powder medicament delivered via the device pertaining to the present invention comprises at least one excipient in addition to the active agent or agents. These excipients are generally chosen from a group comprising monosaccharides (glucose, arabinose, etc.), disaccharides (lactose, saccharose, maltose, etc.), oligo- and polysaccharides (dextran, etc.), polyalcohols (sorbite, mannite, xylite), salts (sodium chloride, calcium carbonate, etc.) or combinations thereof. According to the present invention, the medicament in dry powder form comprises lactose as the excipient. The medicament in dry powder form comprises fine or coarse excipients particles preferably having various particle size ranges in order to deliver the required amount to the lungs.

The active agent or the active agents comprised in the dry powder medicament which is stored in blister packages used in the device pertaining to the present invention can be selected from a group comprising cromolyns, anti-infectives, antihistamines, steroids, antiinflammatories, bronchodilators, leukotirene inhibitors, PDE IV inhibitors, antitussives, diuretics, anticholinergics, hormones, xanthines and pharmaceutically acceptable combinations thereof.

The active agent comprised in the medicament in dry powder form delivered via the inhaler pertaining to the present invention is preferably selected from a group comprising tiotropium, oxitropium, flutropium, ipratropium, glicopironium, flunisolid, beclomethasone, budesonide, fluticasone, mometasone, ciclesonide, rofleponide, dexamethasone, montelukast, methylcyclopropane acetic acid, sodium cromoglicat, nedocromil sodium, Npropylene, teophylline, roflumilast, ariflo (cilomilast), salmeterol, salbutamol, formoterol, terbutaline, carmoterol, indacaterol, cetirizine, levocetirizine, efletirizine, fexofenadine and their racemates, free base, enantiomers or diastereomers and their pharmaceutically acceptable salts, solvates and/or hydrates or a combination of said active agents.

The device pertaining to the present invention is used in the administration of the medicament in dry powder form which is utilized in the treatment of many respiratory diseases, particularly in asthma, chronic obstructive pulmonary disorder (COPD) and allergic rhinitis. Accordingly, the respiratory diseases include, but not restricted to, allergic or non-allergic asthma at any phases, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), exacerbation of airways hyperactivity, bronchiectasis, chronic obstructive pulmonary including emphysema and chronic bronchitis, airways or lung diseases (COPD, COAD or COLD), pneumoconiosis, aluminosis, anthracosis, asbestosis, chalicosis, ptilosis, siderosis, silicosis, tabacosis and byssinosis. The device pertaining to the invention can be used in prophylactic or symptomatic treatment. In addition, the medicament in dry powder form which is preferably used in the symptomatic treatment of allergic asthma and COPD is adniinistered to the patient via the device pertaining to the present invention.

The inhaler pertaining to the present invention is compared with the inhaler existing in the prior art and marketed under Diskus trade mark which does not have apertures to create turbulence. This comparison is based on DUSA analyses defined in American pharmacopeia which was conducted for these two inhalers comprising the same dry powder medicament in the same amount. 10 DUSA (Dose Uniformity Sampling Apparatus) analyses were conducted for each inhaler and the average values are taken into consideration. DUSA analyses of both inhalers are given in the tables below: Table 1 : Comparative DUSA analysis results of device 1 and device 2

Table 2: Comparative DUSA analysis results of device 1 and device 2

Taking the procedure included in USP (United States Pharmacopeia) publication as a reference in the DUSA analyses conducted, the tables above are obtained as a result of the analyses conducted in the condition that the volume of the air entering the inhaler is 30 L/min and 60 L/min and the patient inhales 4L of air in each inhalation. In the table above, device 1 represents the inhaler pertaining to the present invention and the device 2 represents an inhaler which does not hold the specifications described in the invention. In these tables, it is displayed what percentage of the active agent comprised in the dry powder medicament entrained by the air which passes through the air inlet and enters the inhaler with 30 L/min and 60 L/min flow speed is delivered to the oral cavity of the patient. The amount of dry powder medicament contained in each blister is 13 mg in table 1 and 2; however, similar results were obtained in the conditions that the dry powder medicament in the blister is different than 13 mg. As can clearly be seen in the tables, there is a significant difference between the average DUSA values of the inhaler pertaining to the invention (device 1) and the device 2. Thus, it is proved that the inhaler pertaining to the present invention makes a significant difference compared with the inhaler in the prior art which do not hold the specifications defined in the invention.

In the tables below, DUSA analyses of 3 inhalers holding the same specifications are compared and the effects of manufacturing flaws of the device on the delivery of the active agent is illustrated. In the analyses conducted, the amount of dry powder medicament contained in each blister is 13 mg; however, similar results were obtained in the conditions that the dry powder medicament in the blister is different than 13 mg. The results given in tables 3 and 4 are the results of the analyses conducted in the condition that the volume of the air entering the inhaler is 30 L/min and 60 L/min respectively and the patient inhales 4 L of air in each inhalation.

Claims

1. An inhaler (1) suitable for delivery of the medicament in dry powder form from a blister package (15) composed of a plurality of blister pockets (15a) each of which comprises medicament in dry powder form and which are spaced at equal intervals; said inhaler comprising:

- a mouthpiece (14) enabling the patient to inhale the medicament in dry powder form from the opened blister pocket (15a) ,

- a rotatable mouthpiece cover (2) covering the mouthpiece (14),

- a gear mechanism enabling the blister package (15) to be indexed and the medicament in dry powder form to become ready for inhalation,

- a housing (10) situated between the upper housing member (4a) and the lower housing member (4b) in which the blister package (15) and the gear mechanism are enclosed,

- at least one air inlet (22) allowing the external air in the device (1), and

- a manifold (20) through which the air entering from the air inlet (22) passes, characterized in the apertures (20e; 20f) on the opposite walls (A; B) in the second part (20d) of the manifold that is partitioned off from the first part (20c) of the two-part manifold (20) where the external air entering in the device through at least one air inlet (22) upon the inhalation of the patient entrains the dry powder medicament in the blister (15a) in order to create turbulence.

2. The inhaler (1) according to claim 1, wherein at least one aperture is positioned on each of the opposite walls (A, B) in the second part (20d) of the manifold.

3. The inhaler (1) according to claim 2, wherein the apertures (20e, 20f) on each of the opposite walls (A, B) in the second part of the manifold are preferably asymmetrically positioned with respect to each other.

4. The inhaler (1) according to claim 2, wherein the cross-section of each aperture (20e, 20f) on the opposite walls (A, B) in the second part of the manifold is in the range of 0,01 mm² to 27 mm².

5. The inhaler (1) according to claim 2, wherein the cross-section of each aperture (20e, 20f) on the opposite walls (A, B) in the second part of the manifold is preferably in the range of 0,01 mm² to 7 mm².

6. The inhaler (1) according to claim 1, wherein there positioned preferably a circular aperture with four sub-apertures on the edge of each partitioned part (20c, 20d) of the manifold which is close to the blister (15a).

7. The inhaler (1) according to claim 6, wherein the distance between the centers of the apertures with four sub-apertures (20a, 20b) on the edge of each partitioned part (20c, 20d) of the manifold which is close to the blister (15a) is in the range of 3,0 mm to 3,8 mm.

8. The inhaler (1) according to claim 1, wherein the housing (10) preferably encloses the beak (16) that provides the blister pack to be peeled and the manifold (20).

9. The inhaler (1) according to claim 1, wherein a restricted path is arranged with the protrusions (23a, 23b; 24a, 24b) on the upper and lower housing members.

10. The inhaler (1) according to claim 1, wherein the mouthpiece cover (2) is rotationally moved by being slid on the upper (4a) and the lower (4b) housing member.

11. The inhaler (1) according to any one of the preceding claims, wherein the mouthpiece cover (2) can solely be in two positions:

the mouthpiece (14) is completely covered and the device (1) is on standby mode when the mouthpiece cover (2) is in the first position,

one dose of the medicament in dry powder form is ready for inhalation upon the actuation of the device (1) when the mouthpiece cover (2) is in the second position.

12. The inhaler (1) according to claim 1, wherein there is a carved part (2a) in one end of the mouthpiece cover providing to rotate the mouthpiece cover easily.

13. The inhaler (1) according to claim 1, wherein all components of the gear mechanism is directly or indirectly engages with each other.

14. The inhaler (1) according to claim 1 or 13, wherein said gear mechanism is composed of; the drive gear (12) which provides to actuate the device (1) by transmitting the movement of the mouthpiece cover (2) to the indexing ratchet wheel (3);

the indexing wheel (8) which synchronizes with the indexing ratchet wheel (3) and enables the blister package (15) to be indexed;

the winding wheel gear (6) which moves the winding wheel (13) via the mechanism wheel (5) upon the rotation of the indexing wheel (8);

the pinion gear (11) and the base gear (7) that provide to transmit the movement of the indexing wheel (8) to the counter wheel (9);

the counter wheel (9) which displays the number of the unused blister pockets (1 a) remained in the device (1).

15. The inhaler (1) according to claim 1, wherein there is at least one air inlet (22) providing the air flow on the upper housing member (4b).^*

16. The inhaler (1) according to claim 15, wherein the air inlet (22) that the external air enters the device has been designed not to be close to the parts where the patient holds the device (1) in order not to hinder the airflow.

17. The inhaler according to any of the proceeding claims, further comprising a blister package (15) composed of a plurality of blister pockets (15a) each of which comprises medicament in dry powder form and which are spaced at equal intervals.

18. The inhaler (1) according to claim 1, wherein the blister package (15) it comprises is preferably a blister strip.

19. The inhaler (1) according to claim 1 or 18, wherein the blister package (15) it comprises is preferably peelable.

20. The inhaler (1) according to claim 19, wherein the lid (15b) and the base (15c) sheets composing the blister package (15) preferably comprises a plurality of layers.

21. The inhaler (1) according to claim 20, wherein the layers constituting the lid (15b) and the base (15b) sheets of the blister package are chosen from a group comprising polymeric layers preferably made of various polymeric substances, aluminum foil and fluoropoylmer film.

22. The inhaler (1) according to claim 21, wherein at least one of the layers constituting the lid (15b) and the base (15b) sheets of the blister package comprise at least one of the desiccant agents preferably including silica gel, zeolite, alumina, bauxite, anhydrous calcium sulfate, activated carbon and clay which has the property of water absorption.

23. The inhaler (1) according to claim 21, wherein the thickness of the aluminum foil comprised in the lid or the base sheet of the blister package is preferably in the range of 5 to 80 μηι, more preferably in the range of 15 to 65 μπι.

24. The inhaler (1) according to claim 21, wherein the thickness of the polymeric layer comprised in the lid (15b) or the base sheet (15c) of the blister package is preferably in the range of 5 to 100 μιη, more preferably in the range of 15 to 60 μπι.

25. The inhaler (1) appropriate for delivery of the medicament in dry powder form according to any one of the preceding claims, wherein said medicament in dry powder form comprises at least one active agent selected from a group comprising cromolyns, anti-infectives, antihistamines, steroids, anti-inflammatories, bronchodilators, leukotirene inhibitors, PDE IV inhibitors, antitussives, diuretics, anticholinergics, hormones, xanthines and pharmaceutically acceptable combinations thereof.

26. The inhaler (1) appropriate for delivery of the medicament in dry powder form according to any one of the preceding claims, wherein said medicament in dry powder form is used in monotherapy or combined therapy.

27. The inhaler (1) appropriate for delivery of the medicament in dry powder form according to any one of the preceding claims, wherein said medicament comprises at least one excipient along with the active agent or agents it comprises.

28. The inhaler (1) appropriate for delivery of the medicament in dry powder form according to claim 27, wherein the excipients comprised by said dry powder medicament can be selected from a group comprising monosaccharides (glucose, arabinose, etc.), disaccharides (lactose, saccharose, maltose, etc.), oligo- and polysaccharides (dextran, etc.), polyalcohols (sorbite, mannite, xylite), salts (sodium chloride, calcium carbonate, etc.) or combinations thereof.

29. The inhaler appropriate for delivery of the medicament in dry powder form according to claim 27 or 28, wherein the excipient comprised in the dry powder medicament is preferably lactose.